Psyched Wellness Ltd. (CSE: PSYC) has announced it has entered into secured term notes with Gotham Green Fund, L.P. and Gotham Green Fund (Q), L.P. for an aggregate principal amount of US$244,541. The proceeds are designated for operating expenses and inventory purchases related to the company's AMA brand business. The transaction has been classified as a related party transaction under Canadian securities regulations, a detail investors in the life sciences company may wish to note carefully.

Key Points

  • Psyched Wellness Ltd. (CSE: PSYC | OTCQB: PSYCF | FSE: 5U9) is a Canadian life sciences company focused on Amanita Muscaria-derived wellness products.
  • The company has entered into secured term notes totalling US$244,541 with Gotham Green Fund, L.P. and Gotham Green Fund (Q), L.P.
  • The loan matures on September 9, 2028, bearing interest at SOFR plus 5% per annum, compounded annually.
  • Investors should watch how the AMA brand deploys the proceeds across inventory and operating costs.

Loan Structure and Interest Terms Under the Psyched Wellness AMA Brand Financing

The secured term notes carry an interest rate equal to the Secured Overnight Financing Rate (SOFR) plus 5% per annum, compounded annually. All accrued interest and the principal amount of US$244,541 are payable on the maturity date of September 9, 2028. Each note is secured by a continuing security interest over all assets and property of the company directly related to its AMA brand business, the announcement states. The company indicated that loan proceeds will fund operating expenses and inventory purchases tied to that brand.

Related Party Classification and MI 61-101 Exemptions Applied

Psyched Wellness has disclosed that this transaction constitutes a related party transaction under Multilateral Instrument 61-101, as the lenders — together with their affiliates and co-investors — jointly control more than 10% of the company's outstanding common shares. The company states it is relying on exemptions from formal valuation and minority shareholder approval requirements under Sections 5.5(a) and 5.7(1)(a) of MI 61-101. The basis for these exemptions is that the fair market value of the transaction does not exceed 25% of the company's market capitalisation, according to the release.

Psyched Wellness Business Focus and AMA Brand Context

Psyched Wellness describes itself as a Canadian-based health supplements company dedicated to distributing mushroom-derived products and associated consumer packaged goods. The company's stated objective is to develop premium mushroom-derived products with the potential to become a leading North American brand in the functional food category. This financing is specifically earmarked to support the AMA brand's operational continuity, including inventory replenishment. The immediate share price impact was not clear from available public information.